Xia Wei Selected Research

Xia Wei Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 06/2016
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 11/2017
4	Heart Arrest (Cardiac Arrest) 03/2015 - 08/2008
3	Emphysema 01/2022 - 07/2018
3	Inflammation (Inflammations) 01/2021 - 01/2015
3	Brain Edema (Cerebral Edema) 10/2015 - 08/2008
2	Ischemic Stroke 01/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 11/2020 - 06/2018
2	Hypoxia (Hypoxemia) 01/2019 - 01/2014
2	Infarction (Infarctions) 01/2019 - 10/2015
2	Ischemia 01/2019 - 04/2008
2	Lymphoma (Lymphomas) 01/2019 - 04/2015
2	Brain Ischemia (Cerebral Ischemia) 01/2019 - 04/2008
2	Ventricular Fibrillation 03/2015 - 01/2015
2	Neurologic Manifestations (Neurological Manifestations) 03/2015 - 08/2008
2	Asphyxia (Suffocation) 11/2012 - 08/2008
1	Asthenozoospermia 11/2022
1	Insulin Resistance 05/2022
1	Necrosis 03/2022
1	Hemorrhage 01/2022
1	Schizophrenia (Dementia Praecox) 01/2022
1	Disease Resistance 01/2022
1	Membranous Glomerulonephritis (Membranous Nephropathy) 12/2021
1	Liver Neoplasms (Liver Cancer) 10/2021
1	Carcinogenesis 01/2021
1	Dysbiosis 01/2021
1	Gout 01/2021
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Fatigue 12/2020
1	Stomach Neoplasms (Stomach Cancer) 11/2020
1	Hepatitis 11/2020
1	Infections 11/2020
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020
1	Acute Promyelocytic Leukemia 09/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2017
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
4	GoldIBA 01/2021 - 11/2017
4	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2015 - 11/2012
3	Amino Acids FDA Link 11/2022 - 01/2019
3	Neuroprotective AgentsIBA 01/2022 - 11/2012
3	Caspase 3 (Caspase-3)IBA 01/2019 - 08/2008
2	ResveratrolIBA 01/2022 - 12/2012
2	Small Interfering RNA (siRNA)IBA 11/2020 - 06/2018
2	Mitogen-Activated Protein KinasesIBA 11/2020 - 06/2018
2	AntioxidantsIBA 01/2019 - 12/2012
2	prednylidene (Pred)IBA 07/2018 - 11/2017
2	Halothane (Fluothane)FDA Link 08/2008 - 04/2008
1	DefensinsIBA 11/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	PolymersIBA 03/2022
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2022
1	pinocembrinIBA 01/2022
1	QuercetinIBA 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	puerarinIBA 01/2022
1	gingerolIBA 01/2022
1	Carbon MonoxideIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	VitaminsIBA 01/2022
1	FlavonoidsIBA 01/2022
1	Therapeutic UsesIBA 12/2021
1	tetrandrineIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	Circulating Tumor DNAIBA 10/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Lipid AIBA 01/2021
1	Mannose (D-Mannose)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	FructoseIBA 01/2021
1	Volatile Fatty AcidsIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	Carbon Nanotubes (Carbon Nanotube)IBA 11/2020
1	Antiviral Agents (Antivirals)IBA 11/2020
1	CollagenIBA 11/2020
1	Fluorouracil (Carac)FDA LinkGeneric 11/2020
1	obeticholic acidIBA 01/2020
1	Arsenic Trioxide (Trisenox)FDA Link 09/2019
1	MelatoninIBA 09/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	pleiotrophin (HARP)IBA 01/2019
1	CateninsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Superoxide DismutaseIBA 01/2019
1	Capsules (Microcapsules)IBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	Excitatory Amino AcidsIBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019

Therapy/Procedure

4	Therapeutics 01/2022 - 12/2015
4	Resuscitation 03/2015 - 08/2008
3	Cardiopulmonary Resuscitation (CPR) 03/2015 - 08/2008
2	Aftercare (After-Treatment) 01/2022 - 01/2019
2	Hematopoietic Stem Cell Transplantation 01/2019 - 04/2015
1	Mastectomy (Mammectomy) 12/2020
1	Drug Therapy (Chemotherapy) 12/2020
1	Segmental Mastectomy (Lumpectomy) 12/2020
1	Adjuvant Chemotherapy 12/2020
1	Transplantation 01/2019
1	Tibetan Traditional Medicine (Traditional Tibetan Medicine) 01/2019